Perspective: the patient edition

Blue Latitude Health|8th April 2020

During the last decade, we have witnessed the rise of the empowered patient, who takes control over his or her health and is less reliant on healthcare professionals.

This has driven another trend – value-based care, which has caused pharmaceutical companies to move away from a product-centric approach and focus instead on patient outcomes.

In this issue of Perspective magazine, we explore how the industry can place a greater emphasis on patient-centricity, and how pharmaceutical companies are working with patients across the product lifecycle to develop therapies that better serve their unmet needs.

Download the magazine to learn:

• A patient’s view on how pharma can be more patient-centric

• Tips on patient engagement

• The importance of rational and emotional creative campaigns

• The ALS patient journey

• An article on CAR-T service design

• Thought provoking content on clinical trial access and the social determinants of healthcare, and on precision and personalised medicine.

 

If you would like to find out more about how we can help your brand to reach and engage with your customers in innovative ways, please get in touch with hello@bluelaitude.com

Our content has moved

Blue Latitude Health|18th November 2020

We’re posting all new articles on our parent website fishawack.com

read more

Fishawack Health launches Delta Magazine

Blue Latitude Health|17th November 2020

Our parent company Fishawack Health has launched a new magazine with a first issue unpacking rare disease.

read more

In the precision medicine era, the line between products and services is blurred

Amit Sheinholtz and Ilektra Safari|27th August 2020

Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?

read more